镰状细胞病患者静脉血栓栓塞发生率增加:危险因素、复发及对死亡率的影响
在6237例镰状细胞病患者中,11.2%发生静脉血栓栓塞(VTE),其中肺栓塞(±深静脉血栓)占51.6%。重症患者40岁时VTE累积发生率为17.1%,高于匹配哮喘对照组的8.0%。VTE与死亡风险增加相关(HR=2.88),重症患者5年复发率为36.8%。
要点
- 镰状细胞病患者VTE发生率为11.2%,肺栓塞(±深静脉血栓)占51.6%。
- 重症患者40岁时VTE累积发生率为17.1%,匹配哮喘对照组为8.0%。
- VTE与死亡风险增加相关(HR=2.88;95%CI:2.35-3.52)。
核心结论
- 在这项基于人群的研究中,镰状细胞病患者的VTE发生率高于匹配对照,且与死亡率增加相关。
- 重症镰状细胞病患者VTE复发率高,提示可能需要延长抗凝治疗。
研究设计与样本
- 基于人群的队列研究,纳入6237例镰状细胞病患者,并与匹配对照(哮喘患者)比较VTE发生率。
- 同时分析镰状细胞病患者发生VTE的危险因素、复发及对死亡率的影响。
主要发现
- 6237例镰状细胞病患者中,696例(11.2%)发生VTE:358例(51.6%)为肺栓塞(±深静脉血栓),179例(25.7%)仅为下肢深静脉血栓,158例(22.7%)为上肢深静脉血栓。
- 40岁时VTE累积发生率:重症镰状细胞病患者(每年住院≥3次)为17.1%,匹配哮喘对照组为8.0%。
- 镰状细胞病患者中,女性VTE风险增加(HR=1.22;95%CI:1.05-1.43),重症疾病患者VTE风险增加(HR=2.86;95%CI:2.42-3.37)。
- 重症镰状细胞病患者5年VTE复发率为36.8%。
- VTE与死亡风险增加相关(HR=2.88;95%CI:2.35-3.52)。
临床怎么用
- 作者认为,重症镰状细胞病患者VTE复发率高,提示可能需要延长抗凝治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Previous reports show increased incidence of venous thromboembolism [VTE, deep-vein thrombosis (DVT) and pulmonary embolus (PE)] in sickle cell disease (SCD) patients but did not account for frequency of hospitalization. We determined the incidence of VTE in a SCD cohort versus matched controls. For SCD patients, risk factors for incident VTE, recurrence and the impact on mortality were also determined. Among 6237 patients with SCD, 696 patients (11·2%) developed incident-VTE: 358 (51·6%) had PE (±DVT); 179 (25·7%) had lower-extremity DVT only and 158 (22·7%) had upper-extremity DVT. By 40 years of age, the cumulative incidence of VTE was 17·1% for severe SCD patients (hospitalized ≥3 times a year) versus 8·0% for the matched asthma controls. Amongst SCD patients, women (Hazard ratio [HR] = 1·22; 95% confidence interval [CI]: 1·05-1·43) and those with severe disease (HR = 2·86; 95% CI: 2·42-3·37) had an increased risk of VTE. Five-year recurrence was 36·8% in patients with severe SCD. VTE was associated with increased risk of death (HR = 2·88, 95% CI: 2·35-3·52). In this population-based study, the incidence of VTE was higher in SCD patients than matched controls and was associated with increased mortality. The high incidence of recurrent VTE in patients with severe SCD suggests that extended anticoagulation may be indicated.
引用
- Brunson A, Lei A, Rosenberg AS, et al. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol. 2017. PMID: 28369826. doi:10.1111/bjh.14655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。